← Back to radar
Observation record / GOV.UK 公共动态
MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults
First seen 10/23, 23:44 · Last observed 10/24, 04:44 · Source data is current
Read the original source ↗Source excerptAs with any medicine, the MHRA will keep the safety and effectiveness of deuruxolitinib under close review.
Why it mattersA first-party publication from GOV.UK 公共动态, useful for checking the original wording of public policies, data or events.
30 minutesRank movement—
Building history
1 hourRank movement—
Building history
24 hoursRank movement—
Building history
Publication position history
6 observationsPublication feed in source order. Position changes do not count as heat or momentum.
Open Government Licence v3.0; exceptions apply
View original observation times and ranks
| Observation time (Beijing) | Source position |
|---|---|
| 10/24, 04:44 | 5 |
| 10/24, 03:44 | 4 |
| 10/24, 02:44 | 3 |
| 10/24, 01:44 | 2 |
| 10/24, 00:44 | 2 |
| 10/23, 23:44 | 1 |
Daily aggregate history
| 日期 | Best daily position | Last daily position | Observations |
|---|---|---|---|
| 2026-10-23 | 1 | 1 | 1 |
| 2026-10-24 | 2 | 5 | 5 |